13. 多発性硬化症／視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00418145 (ClinicalTrials.gov) | September 2003 | 2/1/2007 | Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks | Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA) | Multiple Sclerosis | Drug: megadose oral methylprednisolone;Drug: IV methylprednisolone | Fred Lublin | National Multiple Sclerosis Society;Pfizer | Terminated | 18 Years | 50 Years | All | 16 | Phase 3 | United States |